Psychedelic microdosing in reality: An exploration of what people who microdose are consuming and the effects experienced

This research will look at people in New Zealand who are currently microdosing with psychedelic substances and will take samples of the drugs for analysis. Psychological factors such as personality, mental health, and creativity will also be investigated.

What's involved?

New Zealand based microdosers and non-microdosers (serving as controls) will complete a range of measures over three time points.

An online study run over about three months will collect data using psychological questionnaires.

Upon completion of the online questionnaire, participants will have the option to be entered into a prize draw for one of four $200 Countdown Vouchers.

An in-person study is currently recruiting people who are currently microdosing to attend two lab visits, which will involve a number of online and in-person measures, and will require participants to provide the researcher with a sample of their microdose substance for analysis. The initial online questionaire is optional; participants are able to book lab visits without completing this. If this is the case for you, please click this link to book your visit

Eligibility criteria

Inclusion criteria for microdose-consuming participants:

  • 18 years of age and over
  • Currently live in New Zealand
  • Are currently microdosing with psychedelic drugs such as LSD or magic mushrooms

Inclusion criteria for non-microdose consumers:

  • 18 years of age and over
  • Currently live in New Zealand
  • Are not currently microdosing with psychedelics

Contact details

If you have any questions or would like more information, please get in touch:

Estelle Miller
Student Researcher, School of Pharmacy
Email: microdosingnz@outlook.com

Dr Rhys Ponton
Supervisor, School of Pharmacy
Phone: 09 373 7599 ext. 87084
Email: r.ponton@auckland.ac.nz

Further information

Approved by the Auckland Health Research Ethics Committee on 24/04/2022 for three years. 

Also approved by the Health and Disability Ethics Committee on 25/08/2022 for three years.

AHREC Reference number AH23252.

HDEC reference number: EXP 12719

A New Zealand Drug Checking License allows this research to be undertaken.